189 related articles for article (PubMed ID: 22365295)
21. Interventional Radiologists Achieve Equivalent Outcomes and Lower Costs for Totally Implantable Venous Access Device Placement Compared to Operating Room Placement.
Martin B; Witrick B; Sivaraj B; Tyler L; Devane AM; Gimbel RW; Rennert LM
J Vasc Interv Radiol; 2022 Oct; 33(10):1184-1190. PubMed ID: 35842028
[TBL] [Abstract][Full Text] [Related]
22. Routine chest X-ray is not mandatory after fluoroscopy-guided totally implantable venous access device insertion.
Thomopoulos T; Meyer J; Staszewicz W; Bagetakos I; Scheffler M; Lomessy A; Toso C; Becker CD; Morel P
Ann Vasc Surg; 2014 Feb; 28(2):345-50. PubMed ID: 24360633
[TBL] [Abstract][Full Text] [Related]
23. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors for Early Port Infections in Adult Oncologic Patients.
Skummer P; Kobayashi K; DeRaddo JS; Blackburn T; Schoeneck M; Patel J; Jawed M
J Vasc Interv Radiol; 2020 Sep; 31(9):1427-1436. PubMed ID: 32792279
[TBL] [Abstract][Full Text] [Related]
25. Complications related to totally implantable venous access devices in children and adults following lung transplantation.
Cho JK; Acord M; Goldfarb SB; Reddy SN; Goldberg HJ; Courtwright AM
Clin Transplant; 2019 Feb; 33(2):e13465. PubMed ID: 30561770
[TBL] [Abstract][Full Text] [Related]
26. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
27. A comparison of infections and complications in central venous catheters in adults with solid tumours.
Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S
J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of catheter infection rates in converted dialysis catheters versus de novo placement in the setting of chlorhexidine use.
Criddle JM; Hieb RA; White SB; Patel PJ; Hohenwalter EJ; Tutton SM; Rilling WS
J Vasc Access; 2016; 17(2):162-6. PubMed ID: 26660045
[TBL] [Abstract][Full Text] [Related]
29. Difficult removal of totally implantable venous access devices in adult patients: Incidence, risk factors, and management.
Chatani S; Tsukii R; Nagasawa K; Hasegawa T; Murata S; Kato M; Yamaura H; Onaya H; Matsuo K; Watanabe Y; Inaba Y
J Vasc Access; 2023 Sep; 24(5):1150-1157. PubMed ID: 35081814
[TBL] [Abstract][Full Text] [Related]
30. Hemodialysis catheter-related infection: prophylaxis, diagnosis and treatment.
Böhlke M; Uliano G; Barcellos FC
J Vasc Access; 2015; 16(5):347-55. PubMed ID: 25907773
[TBL] [Abstract][Full Text] [Related]
31. Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.
Deerojanawong J; Sawyer SM; Fink AM; Stokes KB; Robertson CF
Thorax; 1998 Apr; 53(4):285-9. PubMed ID: 9741372
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy.
Hong S; Seo TS; Song MG; Seol HY; Suh SI; Ryoo IS
J Vasc Access; 2019 Mar; 20(2):134-139. PubMed ID: 29923460
[TBL] [Abstract][Full Text] [Related]
33. Totally implantable venous access devices in children with medical complexity: preliminary data from a tertiary care hospital.
Geremia C; De Ioris MA; Crocoli A; Adorisio O; Scrocca R; Lombardi MH; Staccioli S; Stella P; Amendola P; Ciliento G; De Peppo F; Campana A
J Vasc Access; 2017 Sep; 18(5):426-429. PubMed ID: 28574141
[TBL] [Abstract][Full Text] [Related]
34. Peripherally inserted central catheter-associated bloodstream infection: Risk factors and the role of antibiotic-impregnated catheters for prevention.
Kagan E; Salgado CD; Banks AL; Marculescu CE; Cantey JR
Am J Infect Control; 2019 Feb; 47(2):191-195. PubMed ID: 30180989
[TBL] [Abstract][Full Text] [Related]
35. Peripheral venous access ports: outcomes analysis in 109 patients.
Bodner LJ; Nosher JL; Patel KM; Siegel RL; Biswal R; Gribbin CE; Tokarz R
Cardiovasc Intervent Radiol; 2000; 23(3):187-93. PubMed ID: 10821892
[TBL] [Abstract][Full Text] [Related]
36. Effect of catheter diameter on left innominate vein in breast cancer patients after totally implantable venous access port placement.
Song MG; Seo TS; Kim YH; Cho SB; Chung HH; Lee SH; Jung E
J Vasc Access; 2018 Nov; 19(6):615-619. PubMed ID: 29560786
[TBL] [Abstract][Full Text] [Related]
37. Principles of subcutaneous port placement.
Gonda SJ; Li R
Tech Vasc Interv Radiol; 2011 Dec; 14(4):198-203. PubMed ID: 22099011
[TBL] [Abstract][Full Text] [Related]
38. Radiologic placement of a low profile implantable venous access port in a pediatric population.
Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
[TBL] [Abstract][Full Text] [Related]
39. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
Ghayyda SN; Roland D; Cade A
J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
[TBL] [Abstract][Full Text] [Related]
40. Follow-up of radiologically totally implanted central venous access ports of the upper arm: long-term complications in 127,750 catheter-days.
Busch JD; Herrmann J; Heller F; Derlin T; Koops A; Adam G; Habermann CR
AJR Am J Roentgenol; 2012 Aug; 199(2):447-52. PubMed ID: 22826411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
